Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Long-term safety and efficacy of risankizumab for the treatment of moderate-to-severe plaque psoriasis: Interim analysis of the LIMMitless open-label extension trial up to 5 years of follow-up
Kim Alexander Papp, Andrew Blauvelt, L. Puig, Mamitaro Ohtsuki, Stefan Beissert, Melinda Gooderham and 11 more
- Rank
- 11 of 1,810
- Percentile
- top 0.7%
- Where
- Journal of the American Academy of Dermatology, 2023
- Citations
- 55
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.